ONEMEDNET CORPORATION Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ONEMEDNET CORPORATION (ONMD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.76 billion shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- ONEMEDNET CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 16.76B shares, a 28.18% increase year-over-year.
- ONEMEDNET CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 14.79B shares, a 43.52% decline year-over-year.
- ONEMEDNET CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 14.56M shares, a 50.22% decline year-over-year.
- ONEMEDNET CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 13.07B shares, a 44765.67% increase year-over-year.
- ONEMEDNET CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 20.08B shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 16.76B shares 10-Q · filed 2026-08-14 | 16.76B shares 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | 14.79B shares S-1/A · filed 2026-07-08 | |||||||
| 2025-12-31 | 15.86B shares S-1/A · filed 2026-07-08 | |||||||
| 2025-09-30 | 14.56M shares 10-Q · filed 2025-11-14 | 12.89M shares 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | 13.07B shares 10-Q · filed 2026-08-14 | 13.07M shares 10-Q · filed 2025-08-13 | 12.99B shares 10-Q · filed 2026-08-14 | 12.99M shares 10-Q · filed 2025-08-13 | ||||
| 2025-03-31 | 26.20B shares S-1/A · filed 2026-07-08 | 26.34M shares 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | 28.99B shares S-1/A · filed 2026-07-08 | 29.14B shares 10-K · filed 2025-04-15 | ||||||
| 2024-09-30 | 29.24M shares 10-Q · filed 2025-11-14 | 29.24M shares 10-Q · filed 2025-11-14 | 14.95M shares 10-Q · filed 2024-12-17 | |||||
| 2024-06-30 | 29.14M shares 10-Q · filed 2025-08-13 | 29.14M shares 10-Q · filed 2025-08-13 | 14.87M shares 10-Q · filed 2024-12-11 | |||||
| 2024-03-31 | 23.28M shares 10-Q · filed 2025-05-14 | 14.04M shares 10-Q · filed 2024-12-05 | ||||||
| 2023-12-31 | 20.08B shares 10-K · filed 2025-04-15 | 12.18B shares 10-K/A · filed 2024-11-05 | ||||||
| 2023-09-30 | 15.10M shares 10-Q · filed 2024-12-17 | 11.48M shares 8-K/A · filed 2024-11-22 | ||||||
| 2023-06-30 | 15.10M shares 10-Q · filed 2024-12-11 | |||||||
| 2023-03-31 | 14.32M shares 10-Q · filed 2024-12-05 | |||||||
| 2022-12-31 | 13.47M shares 8-K/A · filed 2024-11-22 | 13.50B shares 10-K/A · filed 2024-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |